Filing Details
- Accession Number:
- 0001738048-19-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-16 17:56:34
- Reporting Period:
- 2019-12-13
- Accepted Time:
- 2019-12-16 17:56:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434418 | Constellation Pharmaceuticals Inc | CNST | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1602263 | Vhcp Management Ii, Llc | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1602264 | Venrock Healthcare Capital Partners Ii, L.p. | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1615979 | Y Bong Koh | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1615983 | Vhcp Co-Investment Holdings Ii, Llc | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1698082 | P Nimish Shah | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1738048 | Venrock Healthcare Capital Partners Iii, L.p. | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1738053 | Vhcp Management Iii, Llc | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No | |
1750761 | Vhcp Co-Investment Holdings Iii, Llc | C/O Venrock 7 Bryant Park, 23Rd Floor New York NY 10018 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-13 | 400,000 | $34.50 | 4,016,873 | No | 4 | P | Indirect | By Funds |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Funds |
Footnotes
- Consists of an aggregate of 363,640 shares of Common Stock purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III") and 36,360 shares of Common Stock purchased by VHCP Co-Investment Holdings III, LLC ("Co-Invest III") (collectively, the "VHCP III Funds").
- Consists of an aggregate of 2,287,598 shares of Common Stock held by VHCP III, 228,644 shares of Common Stock held by Co-Invest III, 1,067,801 shares of Common Stock held by Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and 432,830 shares of Common Stock held by VHCP Co-Investment Holdings II, LLC ("Co-Invest II" and collectively with VHCP II and the VHCP III Funds, the "VHCP Funds").
- VHCP Management III, LLC ("VHCPM III") is the sole general partner and the sole manager of VHCP III and Co-Invest III, respectively, and may be deemed to own the shares held by VHCP III and Co-Invest III. VHCP Management II, LLC ("VHCPM II") is the sole general partner and the sole manager of VHCP II and Co-Invest II, respectively, and may be deemed to own the shares held by VHCP II and Co-Invest II. Bong Koh and Nimish Shah are the voting members of VHCPM III and VHCPM II. Drs. Koh and Shah, VHCPM II and VHCPM III disclaim beneficial ownership over all shares held by the VHCP Funds except to the extent of their indirect proportionate pecuniary interest therein.